New facility strengthens Agilent’s sustainability commitment and customer engagement; Education Center launched within integrated, green-certified site. MANESAR, India — Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced the inauguration of its India Refurbishment Center at its LEED Platinum-certified facility in Manesar, Haryana. This strategic investment reinforces […]
RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA library preparation solution for Oxford Nanopore Technologies® direct RNA sequencing (SQK-RNA004). The kit enables the detection of more genes, more isoforms, and longer transcripts than existing protocols. It […]
Non-exclusive license for Optimer® binder targeting the next-generation sequencing market Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce a first licensing agreement with Twist Bioscience, a leading synthetic biology and genomics company. Under the terms of the agreement, Aptamer has granted Twist Bioscience a non-exclusive […]
STOCKHOLM, Sweden – Basic Genomics, a company advancing RNA technology to empower next-generation molecular insights, today announced the launch of its RNA BaseCode™ Kit. These innovative kits enable researchers to obtain deeper insight into isoforms, splicing, and transcript complexity, all from standard short-read sequencing platforms. They characterize and quantify RNA isoforms with unprecedented precision and […]
SHANGHAI — On December 10, 2025, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (“Sanyou Bio”) and Wenzhou KanryBio Biotech Co., Ltd. (“KanryBio”) announced a strategic collaboration agreement. The partnership will focus on the joint development of key reagents and products for biomarker assay kits. By integrating Sanyou Bio’s core strengths in innovative biologics discovery with KanryBio’s expertise in kit product development […]
Partnership unites Illumina’s leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO PARK, Calif. — Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and […]
Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers. Innovation has the potential to improve preclinical research by reducing reliance on animal testing through New Approach Methodologies (NAMs) such as organoids and predictive modeling, enabling new directions and scale in advanced biomedical studies. Partnership underscores Bio-Techne’s commitment […]
New priority program opens up exclusive opportunities for collaborative research on transformative clinical potential of DNAe’s flagship tests and to gain preview of breakthrough LiDia-SEQ™ platform LONDON and CARLSBAD, Calif. — DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of […]
Mike Hampton, Chief Commercial Officer, Sapio Sciences Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program. The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale […]
Lausanne, Switzerland – Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Esteban Czwan as Chief Commercial Officer, effective 5th December 2025. Esteban will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets. “We are all […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
